As of Mar 26
| +0.03 / +0.26%|
The 4 analysts offering 12-month price forecasts for Raptor Pharmaceutical Corp have a median target of 19.50, with a high estimate of 33.00 and a low estimate of 5.00. The median estimate represents a +68.69% increase from the last price of 11.56.
The current consensus among 5 polled investment analysts is to Buy stock in Raptor Pharmaceutical Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.